Description
StarletDerma was founded over a decade ago as Nanocyte to develop an epidermal delivery platform for pharmaceuticals derived from jellyfish, before switching from pharmaceuticals to medical cosmetics, using an epidermal delivery product derived from the starlet sea anemone’s protection system for delivering venom to predators
Eliachar:
Concepts to Enhance Efficiency
From the Press:
StarletDerma signs L'Oreal collaboration deal
An article published by Gali Weinreb on Globes, February 2014